Association of Admission Serum Resistin Level with Acute ST-Segment Elevation Myocardial Infarction in Iraqi Patients

Authors

  • Dheyaa J.Kadhim
  • Kassim J.Al-Shamma
  • Adeeb G. Hussein

DOI:

https://doi.org/10.31351/vol22iss1pp90-96

Abstract

Human resistin is an adipokine, with a possible link to coronary heart disease.A few studies were done about resistin in acute phase of ST-segment elevation myocardial infarction (STEMI) especially in Iraqi patients. Accordingly we design a study to investigate the association between resistin concentration and acute phase of STEMI in Iraqi patients.

The present study was carried out at Al-Yarmouk Teaching Hospital from December 2011 until June 2012. Serum resistin levels were measured in 50 patients with acute STEMI (mean age: 58.16 ± 11.73 years) at the first 12 hours of admission and 34 normal controls (mean age: 53.98 ± 15.46 years) matched for age, sex and other risk factors.

 Resistin level in patients with acute STEMI (13.08 ng/mL) was significantly higher than that of the control group (5.31 ng/mL) (p < 0.0001). The study revealed a significant negative correlation between serum resistin level and serum adiponectin level among patients.

Key words: Resistin, acute ST-segment elevation myocardial infarction, adipokines

Downloads

Published

2017-03-28

How to Cite

1.
J.Kadhim D, J.Al-Shamma K, G. Hussein A. Association of Admission Serum Resistin Level with Acute ST-Segment Elevation Myocardial Infarction in Iraqi Patients. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2017 Mar. 28 [cited 2024 Nov. 5];22(1):90-6. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/427